Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
This pilot study explores the feasibility of large-scale non-fasting triglyceride level screening at blood donation centers. Hypertriglyceridemia is a risk factor for cardiovascular disease and acute pancreatitis. Triglyceride levels were measured in 10,176 blood donors at Carter BloodCare North Texas and found 39.2% with moderate and 2.4% with severe hypertriglyceridemia. Predictors of elevated triglycerides included age, male gender, blood pressure, and body mass index, with increased odds in Hispanic and Asian individuals compared to White individuals. Survey results from 50 donors with severe hypertriglyceridemia showed 69% had positive intent to seek medical care. The study highlights the potential of blood donation centers to serve as platforms for public health screening, and scaling low-cost, non-fasting triglyceride screening is feasible. This approach provides an opportunity for early intervention and disease prevention.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jacl.2024.12.013 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Long-Term Safety and Efficacy of Pemafibrate to Treat Hyperlipidemia: Post-marketing Surveillance Over a 24-Month Observation Period in Japan.
Adv Ther
July 2025
Division of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, Jichi Medical University, Tochigi, Japan.
Introduction: Pemafibrate was well tolerated and effective in clinical trials that led to its approval to treat hyperlipidemia. However, these clinical trials typically have limitations and may not sufficiently assess the performance of pemafibrate in the real-world setting. Therefore, the aim of this study was to evaluate the long-term safety and efficacy of pemafibrate in patients with hyperlipidemia in Japan.
View Article and Find Full Text PDFEffect of Ramadan Fasting on Blood Lipid Profile Among Populations in the South Asia Region: A Systematic Review and Meta-Analysis.
Cureus
June 2025
Department of Medical Foundations, Ross University School of Medicine, Bridgetown, BRB.
Ramadan fasting involves abstinence from food and drink during daylight hours for 30 consecutive days. While beneficial effects of Ramadan intermittent fasting (RIF) on cardiometabolic risk factors have been suggested, findings related to blood lipid profiles remain inconsistent, particularly among South Asians, who are highly predisposed to dyslipidemia and cardiovascular disease. This systematic review and meta-analysis aimed to evaluate the effects of RIF on lipid profiles among selected South Asian populations from India, Pakistan, Bangladesh, Nepal, and Sri Lanka.
View Article and Find Full Text PDFPNPLA3 I148M variant links to adverse metabolic traits in MASLD during fasting and feeding.
JHEP Rep
August 2025
Department of Medicine I, University Hospital Schleswig-Holstein, Lübeck, Germany.
Background & Aims: The rs738409 polymorphism is the most abundant genetic risk factor associated with progression of metabolic dysfunction-associated steatotic liver disease (MASLD) to steatohepatitis (MASH) and fibrosis. Although fasting and feeding affect expression, molecular insights into the pathophysiological influence remain scarce.
Methods: We analyzed 353 serum samples of patients with MASLD from two German tertiary centers using nuclear magnetic resonance (NMR)-proteometabolomics.
Development and validation of prediction models for diabetic retinopathy in type 2 diabetes patients.
PLoS One
July 2025
Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Background And Objective: Prediction models enable healthcare providers to perform early risk stratification. This study aimed to develop and internally validate prediction models for 5- and 10-year risks of developing diabetic retinopathy (DR) in the Iranian individuals with type 2 diabetes.
Methods: This study utilized data from individuals with diabetes involved in the Shahroud Eye Cohort Study (ShECS), a prospective cohort study in Iran.